Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?

被引：0
|
作者：
Susanne Beckebaum
Vito R. Cicinnati
机构：
[1] University Hospital Essen,Department of Gastroenterology and Hepatology
[2] University of Duisburg-Essen,Department of General, Visceral and Transplantation Surgery
[3] University Hospital Essen,undefined
[4] University of Duisburg-Essen,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：2
相关论文
共 50 条
  • [21] Impact of combined mycophenolate mofetil and low dose calcineurin inhibitor therapy on T cell function.
    Cicinnati, Vito R.
    Yu, Zhengya
    Klein, Christian G.
    Frilling, Andrea
    Gerken, Guido
    Broelsch, Christoph E.
    Beckebaum, Susanne
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 340 - 340
  • [22] Long-lasting improvement of renal function in pediatric heart transplant recipients treated with low-dose calcineurin inhibitor and mycophenolate mofetil
    Boyer, O.
    Iserin, F.
    Dechaux, M.
    Gubler, M. C.
    Salomon, R.
    Niaudet, P.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1447 - 1447
  • [23] Use of mycophenolate mofetil with/without low-dose calcineurin inhibitor for recipients with impaired renal function after living donor liver transplantation
    Kim, K
    Lee, S
    Park, K
    Hwang, S
    Kim, K
    Ahn, C
    Moon, D
    Ha, T
    Cho, S
    Oh, K
    Kim, Y
    LIVER TRANSPLANTATION, 2004, 10 (06) : C23 - C23
  • [24] Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating cytomegalovirus infection in renal transplant patients.
    Lin, Kuo Jen
    Wang, Hsu-Han
    Lin, Chih-Te
    Pan, Pai-Yen
    Chen, Sy-Yuan
    TRANSPLANTATION, 2024, 108 (09) : 592 - 592
  • [25] Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens
    Dubay, Derek
    Smith, Rob J.
    Qiu, Kenneth G.
    Levy, Gary A.
    Lilly, Leslie
    Therapondos, George
    LIVER TRANSPLANTATION, 2008, 14 (05) : 651 - 659
  • [26] Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
    Barkmann, A
    Nashan, B
    Schmidt, HHJ
    Böker, KHW
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Hoffmann, MW
    Manns, MP
    Klempnauer, J
    Schlitt, HJ
    TRANSPLANTATION, 2000, 69 (09) : 1886 - 1890
  • [27] Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil
    Pascual, J
    Quereda, C
    Zamora, J
    Hernández, D
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3746 - 3748
  • [28] Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction:: a randomised controlled study
    Schlitt, HJ
    Barkmann, A
    Böker, KHW
    Schmidt, HHJ
    Emmanouilidis, N
    Rosenau, J
    Bahr, MJ
    Tusch, G
    Manns, MP
    Nashan, B
    Klempnauer, J
    LANCET, 2001, 357 (9256): : 587 - 591
  • [29] A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
    Zheng Xiang
    Zhang Weijie
    Zhou Hua
    Cao Ronghua
    Shou Zhangfei
    Zhang Shuwei
    Cheng Ying
    Chen Xuchun
    Ding Chenguang
    Tang Zuofu
    Li Ning
    Shi Shaohua
    Zhou Qiang
    Chen Qiuyuan
    Chen Gang
    Chen Zheng
    Zhou Peijun
    Hu Xiaopeng
    Zhang Xiaodong
    Na Ning
    Wang Wei
    中华医学杂志(英文版), 2022, 135 (13) : 1597 - 1603
  • [30] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
12345